Sfoglia per Autore
Time to detection and loss of M184 genotypic mutation among HIV patients treated with 3TC and failing an HAART regimen
2000-01-01 Forbici, F; Zaccarelli, M; Bertoli, A; Baracchini, A; D’Arrigo, R; Trotta, M; Bellocchi, M; Armignacco, O; D’Offizi, G; Tozzi, V; Ippolito, G; Perno, C; Antinori, A
Factors predictive of multinucleoside analogue-resistance mutations in an unselected cohort of HAART-failed patients.
2000-01-01 Antinori, A; D’Arrigo, R; Liuzzi, G; Bellocchi, M; Trotta, M; Bertoli, A; Baracchini, A; Forbici, F; Zaccarelli, M; Narciso, P; De Longis, P; Girardi, E; Ippolito, G; Perno, C
Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure
2001-01-01 Zaccarelli, M; Cingolani, A; Forbici, F; Rizzo, M; Trotta, M; Bertoli, A; Di Giambenedetto, S; D’Arrigo, R; Baldini, F; Liuzzi, G; Ciancio, B; Bellocchi, M; Murri, R; Girardi, E; Ammassari, A; Ippolito, G; De Luca, A; Antinori, A; Perno, C
Factors predictive of virological response after genotyping resistance test (GRT): data from an unselected cohort
2001-01-01 Perno, C; Girardi, E; Trotta, M; D’Arrigo, R; Zaccarelli, M; Forbici, F; Baracchini, A; Bellocchi, M; Liuzzi, G; Narciso, P; De Longis, P; Bertoli, A; Tozzi, V; D’Offizi, G; Ippolito, G; Antinori, A
Genetic heterogenicity of HIV-1 protease in drug-naive and drug-treated HIV-positive patients
2002-01-01 Ceccherini Silberstein, F; Bertoli, A; Forbici, F; Erba, F; Balotta, C; Giannella, S; D’Arrigo, R; Bellocchi, M; Gori, C; Trotta, M; D’Arminio Monforte, A; Antinori, A; Perno, C
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages
2002-01-01 Mollace, V; Salvemini, D; Riley, D; Muscoli, C; Iannone, M; Granato, T; Masuelli, L; Modesti, A; Rotiroti, D; Nistico', Rg; Bertoli, A; Perno, Cf; Aquaro, S
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation
2003-01-01 Zaccarelli, M; Perno, Cf; Forbici, F; Cingolani, A; Liuzzi, G; Bertoli, A; Trotta, Mp; Bellocchi, Mc; Di Giambenedetto, S; Tozzi, V; Gori, C; D(')Arrigo, R; De Longis, P; Noto, P; Girardi, E; De Luca, A; Antinori, A
Identification of the Minimal Conserved Structure of the HIV-Reverse Transcriptase under the Presence and Absence of Drug Pressure
2003-01-01 Ceccherini-Silberstein, F; Santoro, M; Svicher, V; Forbici, F; Gori, C; Esnouf, R; Ciccozzi, M; Ruiz Alvarez, M; D’Arrigo, R; Bellocchi, M; Balotta, C; Bertoli, A; Giannella, S; Cenci, A; Trotta, M; Balzarini, J; D’Arminio Monforte, A; Antinori, A; Perno, C
Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase
2004-01-01 Ceccherini-Silberstein, F; Santoro, M; Svicher, V; Gori, C; Zaccarelli, M; Forbici, F; D’Arrigo, R; Trotta, M; Bellocchi, M; Visco-Comandini, U; Giannella, S; Bertoli, A; Antinori, A; Perno, C
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure
2004-01-01 CECCHERINI SILBERSTEIN, F; Erba, F; Gago, F; Bertoli, A; Forbici, F; Bellocchi, M; Gori, C; D'Arrigo, R; Marcon, L; Balotta, C; Antinori, A; Monforte, A; Perno, Cf
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy
2004-01-23 Violin, M; Cozzi Lepri, A; Velleca, R; Vincenti, A; D'Elia, S; Chiodo, F; Ghinelli, F; Bertoli, A; d'Arminio Monforte, A; Perno, Cf; Moroni, M; Balotta, C
Temporal change in the use of genotypic resistance testing over the years 1999--2003
2004-04-01 Santoro, M; CECCHERINI SILBERSTEIN, F; Gori, C; Svicher, V; Forbici, F; Bellocchi, M; D'Arrigo, R; Bertoli, A; Giannella, S; Trotta, M; Bonfigli, S; Antinori, A; Perno, Cf
Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failed
2004-06-01 Perno, Cf; Cozzi Lepri, A; Forbici, F; Bertoli, A; Violin, M; Stella Mura, M; Cadeo, G; Orani, A; Chirianni, A; De Stefano, C; Balotta, C; d'Arminio Monforte, A
Altered deoxyribonucleotide pools in T-lymphoblastoid cells expressing the multisubstrate nucleoside kinase of Drosophila melanogaster
2005-06-19 Bertoli, A; Franco, M; Balzarini, J; Johansson, M; Karlsson, A
High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations
2005-08-01 CECCHERINI SILBERSTEIN, F; Gago, F; Santoro, M; Gori, C; Svicher, V; Rodríguez Barrios, F; D'Arrigo, R; Ciccozzi, M; Bertoli, A; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Perno, Cf
Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome
2006-01-01 Tozzi, V; Zaccarelli, M; Bonfigli, S; Lorenzini, P; Liuzzi, G; Trotta, M; Forbici, F; Gori, C; Bertoli, A; Bellagamba, R; Narciso, P; Perno, Cf; Antinori, A
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy
2006-04-01 Santoro, M; Svicher, V; Gori, C; Zaccarelli, M; Tozzi, V; Forbici, F; D'Arrigo, R; Trotta, M; Bellocchi, M; Visco Comandini, U; Cenci, A; Bertoli, A; Narciso, P; Antinori, A; Perno, Cf; CECCHERINI SILBERSTEIN, F
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors
2006-07-01 Svicher, V; Sing, T; Santoro, M; Forbici, F; Rodríguez Barrios, F; Bertoli, A; Beerenwinkel, N; Bellocchi, M; Gago, F; d'Arminio Monforte, A; Antinori, A; Lengauer, T; CECCHERINI SILBERSTEIN, F; Perno, Cf
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment
2006-10-01 Aquaro, S; D'Arrigo, R; Svicher, V; Perri, G; Caputo, S; Visco Comandini, U; Santoro, M; Bertoli, A; Mazzotta, F; Bonora, S; Tozzi, V; Bellagamba, R; Zaccarelli, M; Narciso, P; Antinori, A; Perno, Cf
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso
2006-11-01 Nadembega, W; Giannella, S; Simpore, J; CECCHERINI SILBERSTEIN, F; Pietra, V; Bertoli, A; Pignatelli, S; Bellocchi, M; Nikiema, J; Cappelli, G; Bere, A; Colizzi, V; Perno, Cf; Musumeci, S
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2000 | Time to detection and loss of M184 genotypic mutation among HIV patients treated with 3TC and failing an HAART regimen | Forbici, F; Zaccarelli, M; Bertoli, A; Baracchini, A; D’Arrigo, R; Trotta, M; Bellocchi, M; Armignacco, O; D’Offizi, G; Tozzi, V; Ippolito, G; Perno, C; Antinori, A | Intervento a convegno | |
1-gen-2000 | Factors predictive of multinucleoside analogue-resistance mutations in an unselected cohort of HAART-failed patients. | Antinori, A; D’Arrigo, R; Liuzzi, G; Bellocchi, M; Trotta, M; Bertoli, A; Baracchini, A; Forbici, F; Zaccarelli, M; Narciso, P; De Longis, P; Girardi, E; Ippolito, G; Perno, C | Intervento a convegno | |
1-gen-2001 | Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure | Zaccarelli, M; Cingolani, A; Forbici, F; Rizzo, M; Trotta, M; Bertoli, A; Di Giambenedetto, S; D’Arrigo, R; Baldini, F; Liuzzi, G; Ciancio, B; Bellocchi, M; Murri, R; Girardi, E; Ammassari, A; Ippolito, G; De Luca, A; Antinori, A; Perno, C | Intervento a convegno | |
1-gen-2001 | Factors predictive of virological response after genotyping resistance test (GRT): data from an unselected cohort | Perno, C; Girardi, E; Trotta, M; D’Arrigo, R; Zaccarelli, M; Forbici, F; Baracchini, A; Bellocchi, M; Liuzzi, G; Narciso, P; De Longis, P; Bertoli, A; Tozzi, V; D’Offizi, G; Ippolito, G; Antinori, A | Intervento a convegno | |
1-gen-2002 | Genetic heterogenicity of HIV-1 protease in drug-naive and drug-treated HIV-positive patients | Ceccherini Silberstein, F; Bertoli, A; Forbici, F; Erba, F; Balotta, C; Giannella, S; D’Arrigo, R; Bellocchi, M; Gori, C; Trotta, M; D’Arminio Monforte, A; Antinori, A; Perno, C | Intervento a convegno | |
1-gen-2002 | The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages | Mollace, V; Salvemini, D; Riley, D; Muscoli, C; Iannone, M; Granato, T; Masuelli, L; Modesti, A; Rotiroti, D; Nistico', Rg; Bertoli, A; Perno, Cf; Aquaro, S | Articolo su rivista | |
1-gen-2003 | Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation | Zaccarelli, M; Perno, Cf; Forbici, F; Cingolani, A; Liuzzi, G; Bertoli, A; Trotta, Mp; Bellocchi, Mc; Di Giambenedetto, S; Tozzi, V; Gori, C; D(')Arrigo, R; De Longis, P; Noto, P; Girardi, E; De Luca, A; Antinori, A | Articolo su rivista | |
1-gen-2003 | Identification of the Minimal Conserved Structure of the HIV-Reverse Transcriptase under the Presence and Absence of Drug Pressure | Ceccherini-Silberstein, F; Santoro, M; Svicher, V; Forbici, F; Gori, C; Esnouf, R; Ciccozzi, M; Ruiz Alvarez, M; D’Arrigo, R; Bellocchi, M; Balotta, C; Bertoli, A; Giannella, S; Cenci, A; Trotta, M; Balzarini, J; D’Arminio Monforte, A; Antinori, A; Perno, C | Intervento a convegno | |
1-gen-2004 | Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase | Ceccherini-Silberstein, F; Santoro, M; Svicher, V; Gori, C; Zaccarelli, M; Forbici, F; D’Arrigo, R; Trotta, M; Bellocchi, M; Visco-Comandini, U; Giannella, S; Bertoli, A; Antinori, A; Perno, C | Intervento a convegno | |
1-gen-2004 | Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure | CECCHERINI SILBERSTEIN, F; Erba, F; Gago, F; Bertoli, A; Forbici, F; Bellocchi, M; Gori, C; D'Arrigo, R; Marcon, L; Balotta, C; Antinori, A; Monforte, A; Perno, Cf | Articolo su rivista | |
23-gen-2004 | Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy | Violin, M; Cozzi Lepri, A; Velleca, R; Vincenti, A; D'Elia, S; Chiodo, F; Ghinelli, F; Bertoli, A; d'Arminio Monforte, A; Perno, Cf; Moroni, M; Balotta, C | Articolo su rivista | |
1-apr-2004 | Temporal change in the use of genotypic resistance testing over the years 1999--2003 | Santoro, M; CECCHERINI SILBERSTEIN, F; Gori, C; Svicher, V; Forbici, F; Bellocchi, M; D'Arrigo, R; Bertoli, A; Giannella, S; Trotta, M; Bonfigli, S; Antinori, A; Perno, Cf | Articolo su rivista | |
1-giu-2004 | Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failed | Perno, Cf; Cozzi Lepri, A; Forbici, F; Bertoli, A; Violin, M; Stella Mura, M; Cadeo, G; Orani, A; Chirianni, A; De Stefano, C; Balotta, C; d'Arminio Monforte, A | Articolo su rivista | |
19-giu-2005 | Altered deoxyribonucleotide pools in T-lymphoblastoid cells expressing the multisubstrate nucleoside kinase of Drosophila melanogaster | Bertoli, A; Franco, M; Balzarini, J; Johansson, M; Karlsson, A | Articolo su rivista | |
1-ago-2005 | High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations | CECCHERINI SILBERSTEIN, F; Gago, F; Santoro, M; Gori, C; Svicher, V; Rodríguez Barrios, F; D'Arrigo, R; Ciccozzi, M; Bertoli, A; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Perno, Cf | Articolo su rivista | |
1-gen-2006 | Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome | Tozzi, V; Zaccarelli, M; Bonfigli, S; Lorenzini, P; Liuzzi, G; Trotta, M; Forbici, F; Gori, C; Bertoli, A; Bellagamba, R; Narciso, P; Perno, Cf; Antinori, A | Articolo su rivista | |
1-apr-2006 | Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy | Santoro, M; Svicher, V; Gori, C; Zaccarelli, M; Tozzi, V; Forbici, F; D'Arrigo, R; Trotta, M; Bellocchi, M; Visco Comandini, U; Cenci, A; Bertoli, A; Narciso, P; Antinori, A; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
1-lug-2006 | Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors | Svicher, V; Sing, T; Santoro, M; Forbici, F; Rodríguez Barrios, F; Bertoli, A; Beerenwinkel, N; Bellocchi, M; Gago, F; d'Arminio Monforte, A; Antinori, A; Lengauer, T; CECCHERINI SILBERSTEIN, F; Perno, Cf | Articolo su rivista | |
1-ott-2006 | Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment | Aquaro, S; D'Arrigo, R; Svicher, V; Perri, G; Caputo, S; Visco Comandini, U; Santoro, M; Bertoli, A; Mazzotta, F; Bonora, S; Tozzi, V; Bellagamba, R; Zaccarelli, M; Narciso, P; Antinori, A; Perno, Cf | Articolo su rivista | |
1-nov-2006 | Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso | Nadembega, W; Giannella, S; Simpore, J; CECCHERINI SILBERSTEIN, F; Pietra, V; Bertoli, A; Pignatelli, S; Bellocchi, M; Nikiema, J; Cappelli, G; Bere, A; Colizzi, V; Perno, Cf; Musumeci, S | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile